Regulatory Due Diligence in Pharma: A Checklist for Companies
Pharmaceutical regulatory due diligence helps companies evaluate their regulatory compliance, identify potential risks, and verify whether their products and processes meet applicable health authority requirements. It is particularly important during mergers, acquisitions, licensing agreements, product transfers, and market expansion. A structured assessment helps organisations make informed business decisions and address regulatory concerns early.
Why Pharmaceutical Companies Need Regulatory Due Diligence
Pharmaceutical companies must comply with regulatory requirements across different markets. These requirements cover product approvals, manufacturing practices, quality systems, pharmacovigilance, and regulatory documentation. A systematic review helps identify compliance gaps before they affect business transactions or product activities. It also allows companies to understand their regulatory position and address potential issues before they become significant concerns.
Key Areas to Review During Regulatory Due Diligence
An effective regulatory due diligence assessment should cover several important areas:
Regulatory approvals. Review marketing authorisations, product registrations, approval status, renewal dates, and variations.
Regulatory documentation. Examine CTD/eCTD dossiers, regulatory submissions, health authority correspondence, and supporting technical documents.
GMP compliance. Verify GMP certificates, manufacturing licences, inspection reports, and quality management records.
Pharmacovigilance. Assess pharmacovigilance systems, adverse event reporting procedures, and applicable safety obligations.
Labelling compliance. Check approved product information, packaging details, and market-specific labelling requirements.
Post-approval commitments. Identify pending submissions, corrective actions, and outstanding post-approval obligations.
Benefits of Regulatory Due Diligence
A structured assessment helps companies identify documentation gaps, evaluate compliance risks, and understand their regulatory position. It supports informed decision-making during mergers, acquisitions, licensing arrangements, and product transfers. Early identification of potential issues also allows organisations to prioritise corrective actions and improve regulatory readiness.
Best Practices for an Effective Assessment
Use up-to-date regulatory guidelines, maintain organised documentation, and involve experienced regulatory affairs and quality professionals. Record all findings systematically and assign each identified gap a corrective action, responsible owner, and target completion date. Regular reviews help maintain compliance with applicable regulatory expectations.
How MASUU Global Can Support
MASUU Global provides pharmaceutical
regulatory due diligence support through regulatory documentation reviews, compliance assessments, and due diligence activities. This structured approach helps pharmaceutical companies understand their compliance status, identify potential gaps, and strengthen overall regulatory readiness.
